Trials / Conditions / Squamous Cell Carcinoma Mouth
Squamous Cell Carcinoma Mouth
4 registered clinical trials studyying Squamous Cell Carcinoma Mouth — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07460765 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Not Yet Recruiting | Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma NCT07127614 | Al-Azhar University | — |
| Completed | Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study NCT03575598 | University Health Network, Toronto | EARLY_Phase 1 |
| Withdrawn | Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Or NCT02993991 | University Health Network, Toronto | Phase 1 |